Veracyte reported $-7433000 in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Agenus AGEN:US $ -44972000 8.98M
Agilent A:US $ 434M 50M
Anika Therapeutics ANIK:US $ -3381000 173K
Arrowhead Research ARWR:US $ -72909000 114.46M
Biocept BIOC:US $ -2707000 68.54K
Bruker BRKR:US $ 86M 17.4M
Exact Sciences EXAS:US $ -152993000 23.99M
Illumina ILMN:US $ 30M 154M
Immunogen IMGN:US $ -61053000 38.2M
Karyopharm Therapeutics KPTI:US $ -42908000 8.32M
Laboratory Of America LH:US $ 592.3M 109.4M
Myriad Genetics MYGN:US $ -17800000 2.9M
Sangamo Biosciences SGMO:US $ -45734000 473K
Siemens SIE:GR 2.43B 1.1B
Sonic Healthcare SHL:AU $ 948.26M 260.51M
Thermo Fisher Scientific TMO:US $ 2025M 798M
Veracyte VCYT:US $ -7433000 7.82M
Waters WAT:US $ 199.65M 4.18M